Serum IVF, Athens
The “Serum IVF” Centre is family oriented and its policy is simply to deliver excellent services, coupled with a sincere commitment and dedication to highly personalized and compassionate care.
This should be the first choice for the majority of women. Let’s not forget pregnancy is a celebration of life not a disease!
This should be considered only if there is no alternative way to deliver the baby safely or if the mothers health is at risk
Vaginal Birth after Caesarean Section
Successful in approximately 70-80% of women with one previous caesarean section. A detailed discussion between the obstetrician and the pregnant woman is necessary to decide if VBAC is a safe and acceptable option.
This is very new screening test for chromosomal abnormalities ( ie Down’s syndrome). By performing this test we avoid the small but significant risk of pre-term birth and misscariage associated with amniocentisis or CVS. It requires taking a blood sample from the pregnant woman and detecting fetal cells that can subsequently analyzed. It has a sensitivity of 99%.
Starts with pre-conceptual counselling and ends with the safe delivery of the baby. My approach is truly holistic and I aim to combine the woman’s choices and wishes with the most up to date evidence based medicine. No pregnancy is the same and hence every pregnant woman is treated in a unique way.
Sometimes there are pre-existing conditions ( ie hypertnesion, diabetes, obesity, autoimmune disease etc) that make a pregnancy “high risk” this requires closer monitoring and collaboration with other specialists in order to ensure the best possible outcome for both mother and baby.
This test was developed by the late Dr Papanikolaou while he was working in the US in the 1960’s, it have saved millions of women’s lives as it detects early precancerous changes on the uterine cervix, years before these could turn into cancer allowing early effective treatment. its recommended to be performed yearly for the majority of women. Newer advances include the LBC ( liquid based cytology) variant which is much more reliable and testing for HPV oncogenic viruses in appropriate cases.
This should be performed on a yearly basis after the age of 40 for the majority of women.
Families with strong history of ovarian/endometrial cancer or those with oncogenic mutations like BRCA 1,2 should consider following a customised screening program with ultrasonograhy and Ca 125 measurements.
These gene mutations when detected carry a significantly increased risk of developing ovarian/breast cancer at a young age. Genetic counselling, screening and sometimes surgery is needed to reduce the risk.
Infections like chlamydia can affect the reproductive system and affect fertility. Screening is important as It allows early detection and treatment.